Patent classifications
A61N1/37223
Power and data transfer in hearing prostheses
Embodiments presented herein are generally directed to techniques for separately transferring power and data from an external device to an implantable component of a partially or fully implantable medical device. The separated power and data transfer techniques use a single external coil and a single implantable coil. The external coil is part of an external resonant circuit, while the implantable coil is part of an implantable resonant circuit. The external coil is configured to transcutaneously transfer power and data to the implantable coil using separate (different) power and data time slots. At least one of the external or internal resonant circuit is substantially more damped during the data time slot than during the power time slot.
Active Telemetry Response for Hearing Implants
An implantable processor arrangement is described for an active implantable medical device (AIMD) system implanted under the skin of a patient. An implantable communications coil arrangement is configured for transdermal transfer of an implant communications signal. An implantable processor is coupled to and controls the implantable communications coil arrangement so as to operate in two different communications modes. In a normal operation mode, the processor configures the communications coil arrangement for peridermal communication with an external communications coil placed on the skin of the patient immediately over the implantable communications coil arrangement using load modulation of the communications coil arrangement, wherein the implantable communications coil has a resonance frequency matching the transmission frequency. In a long range telemetry mode, the processor configures the communications coil arrangement for extradermal communication with an external telemetry coil located distant from the skin of the patient immediately over the implantable communications coil arrangement.
IMPLANTABLE LEAD
An implantable wireless lead includes an enclosure, the enclosure housing: one or more electrodes configured to apply one or more electrical pulses to a neural tissue; a first antenna configured to: receive, from a second antenna and through electrical radiative coupling, an input signal containing electrical energy, the second antenna being physically separate from the implantable neural stimulator lead; one or more circuits electrically connected to the first antenna, the circuits configured to: create the one or more electrical pulses suitable for stimulation of the neural tissue using the electrical energy contained in the input signal; and supply the one or more electrical pulses to the one or more electrodes, wherein the enclosure is shaped and arranged for delivery into a subject's body through an introducer or a needle.
Implantable medical device for stimulating a human or animal heart employing an automatic choice between different impedance measuring modes
An implantable medical device for stimulating a human/animal heart having a stimulation unit which stimulates the His bundle and a detection unit which detects an electrical signal at the His bundle. The device performs: a) determining a first value of a parameter of a first measuring pulse measured between a first electrode pole and a housing; b) determining a second value of the same parameter of a second measuring pulse measured between the first electrode pole and a second electrode pole; c) comparing the first and second values; d) determining, based on the comparing step, whether the first or second measuring pulses enables a higher available level control range of the analog-to-digital converter; e) measuring an impedance in a unipolar manner between the first electrode pole and the housing or in a bipolar manner between the first electrode pole and the second electrode pole depending on the determining step.
Methods and systems for treating cardiovascular disease using an implantable electroacupuncture device
A method of treating cardiovascular disease in a patient includes generating, by an implantable stimulator configured to be implanted beneath a skin surface of the patient, stimulation sessions at a duty cycle that is less than 0.05 and applying, by the implantable stimulator in accordance with the duty cycle, the stimulation sessions to a location, within the patient, that is associated with the cardiovascular disease. The duty cycle is a ratio of T3 to T4. Each stimulation session included in the stimulation sessions has a duration of T3 minutes and occurs at a rate of once every T4 minutes.
STIMULATION AND ELECTROPORATION ASSEMBLY
An apparatus includes a body configured to be at least partially implanted on or within a recipient and a plurality of electrodes positioned along the body. The plurality of electrodes includes a first set of electrodes configured to apply electrical stimulation signals to at least a portion of the recipient. The plurality of electrodes further includes a second set of electrodes configured to apply an electric field to cell membranes of the recipient, the electric field configured to increase a permeability of the cell membranes to a substance.
IMPLANTABLE AND EXTERNAL DEVICE AND METHOD
A device includes: a wireless power receiver configured to receive wireless power from an external device external to a body; a capacitor configured to store therein the wireless power received by the wireless power receiver; a wireless transceiver configured to transmit, to the external device, information associated with stored energy of the capacitor and scheduled energy to be used; and a processor configured to operate with the stored energy of the capacitor and process a biosignal of the body, wherein an operation of the external device and an operation of the device are synchronized, and a wireless power quantity of the wireless power to be received by the wireless power receiver from the external device is determined based on the information transmitted from the wireless transceiver to the external device.
COCHLEAR IMPLANT STIMULATION CALIBRATION
Cochlear implant systems can include a cochlear electrode and a stimulator in electrical communication with the cochlear electrode. The stimulator can be in communication with a controller, which is in communication with a testing circuit and a switching network. The stimulator can include a plurality of source elements. The controller can control the switching network to place the plurality of source elements into communication with the testing circuit. The controller can further cause one of the plurality of source elements to emit an electrical current and can determine an amount of electrical current emitted from the source element using the testing circuit. The controller can compare the determined amount of electrical current emitted by the source element with a prescribed current. The controller can adjust the output of each of the plurality of source elements based on the determined amount of electrical current emitted by the stimulator.
Active titration of one or more nerve stimulators to treat obstructive sleep apnea
The present disclose generally relates to systems and methods for active titration of one or more cranial or peripheral nerve stimulators to treat obstructive sleep apnea. The active titration can be accomplished in an automated fashion by a closed-loop process. The closed-loop process can be executed by a computing device that includes a non-transitory memory storing instructions and a processor to execute the instructions to perform operations. The operations can include defining initial parameters for the one or more cranial or peripheral nerve stimulators for a patient; receiving sensor data from sensors associated with the patient based on a stimulation with the one or more cranial or peripheral stimulators programmed according to the initial parameters; and adjusting the initial parameters based on the sensor data.
METHOD AND DEVICE TO ENHANCE WASTE CLEARANCE IN THE BRAIN
Medical devices and methods of medical treatment for the electrical stimulation of target nerves to enhance waste clearance in the brain for treating neurological disorders such as Alzheimer's disease (AD), including prodromal, mild cognitive impairment (MCI) and early stage Alzheimer's disease.